Date: 26th March 2018
Location: Les Jardins du Maris, Paris, France
This advisory board aims to gather expert feedback on the current trends and unmet needs in asthma management, the results of the “Still Fighting for Breath” global survey, the usefulness of phenotyping and endotyping to guide choice of biologic treatment in appropriate patients in day-to-day clinical practice and the non-biologic treatment options in the management of asthma, including emerging triple combination therapies.